The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPCT.L Share News (WPCT)

  • There is currently no data for WPCT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Troubled Woodford Patient Capital Suffers Further Asset Write-Down

Mon, 04th Nov 2019 09:32

(Alliance News) - Woodford Patient Capital Trust PLC said Monday a brace of asset revaluations will result in a fall in net asset value of 4.3 pence per share.

The investment trust reported that Link Fund Solutions Ltd cut the value of the stake in IH Holdings International Ltd held by Woodford Patient Capital amid a "delay in operational progress" at the nuclear energy firm. This has resulted in the trust's NAV being cut by 5.0 pence per share.

Meanwhile, Link upwardly revalued another asset which had been written down in September amid a "challenging fundraising environment". The unnamed firm has since secured funding, boosting Woodford Patient Capital's NAV per share by 0.7 pence.

The two changes together result in a net change to NAV of negative 4.3p.

At the end of 2018, Woodford Patient Capital reported NAV per share stood at 97.61 pence.

The investment trust - currently managed by troubled stock picker Neil Woodford - has been suffering from a number of asset revaluations in recent months.

In late October, the board of the trust announced FTSE 100-listed Schroders PLC will become portfolio manager from the end of 2019, and the trust will be subsequently renamed Schroder UK Public Private Trust PLC.

Shares in Woodford Patient Capital Trust were 6.9% lower at 35.30 pence in London on Monday.

By Ahren Lester; ahrenlester@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
11 Jun 2018 09:36

CORRECT (June 8): Syncona, Woodford And Arix Investee Plans ADS Offer

(Correcting Syncona and Woodford's shareholding value in Autolus Therapeutics following the ADS offering)LONDON (Alliance News) - Healthcare investor Syncona Ltd said Friday that its an

Read more
24 Apr 2018 08:58

Woodford Patient Capital Net Asset Value Falls As Prothena Trial Fails

LONDON (Alliance News) - FTSE 250-listed Woodford Patient Capital Trust's net asset value for 2017 dropped as one of its portfolio companies Prothena Corp, reported a failed trial of one of in

Read more
23 Apr 2018 17:47

Woodford Patient Investee Prothena Reports Disappointing Trial Results

LONDON (Alliance News) - Woodford Patient Capital Trust PLC said Monday that investee Prothena Corp PLC's trial investigating NEOD001 for treating AL Amyloidosis has not met its primary trust

Read more
14 Mar 2018 13:12

BP Marsh Has Strong February After Positive Results - QuotedData

LONDON (Alliance News) - Net asset value moves during February were a result of dollar strength rather than a change in the local currency value of assets, according to a by a

Read more
4 Aug 2016 08:52

Assets fall significantly at Woodford Patient Capital Trust

(ShareCast News) - Woodford Patient Capital Trust announced its unaudited half-yearly financial report for the period from 1 January to 30 June on Thursday, with net assets falling to £717.89m from £814.86m a year ago. The FTSE 250 firm's net asset value fell to 86.81p from 101.86p, while its share

Read more
8 Jul 2016 12:18

Gold Funds Rally In June But UK Funds Stung By Brexit - QuotedData

Read more
8 Jul 2016 12:12

Best And Worst Performing London-Listed Funds In June - QuotedData

Read more
3 Jun 2016 15:04

UK Dividends Calendar - Next 7 Days

Read more
22 Mar 2016 08:25

Woodford Patient Capital To Pay 2015 Dividend As Net Asset Value Slips

Read more
22 Mar 2016 08:03

Woodford Patient Capital Trust declines in maiden results

(ShareCast News) - Neil Woodford's latest investment vehicle Woodford Patient Capital Trust saw net asset value fall during 2015, by 2.6% to 97.38p, it reported in its maiden results on Tuesday. The FTSE 250 company nonetheless described its investment opportunities as "better, deeper and richer" th

Read more
2 Feb 2016 07:57

Imperial Innovations Takes Part In MISSION Therapeutics Funding Round

Read more
13 Jan 2016 07:56

Woodford Patient Capital Eyes Further Capital Raising (ALLISS)

Read more
8 Jan 2016 06:55

PRESS: Woodford Calls For Break-Up Of GlaxoSmithKline - BBC

Read more
17 Dec 2015 11:46

Estate Agency Purplebricks Trades 6% Lower On First Day On AIM (ALLIPO)

Read more
10 Dec 2015 07:01

Neil Woodford Sells Out Of Rolls-Royce After Losing Confidence (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.